Article
Expert Review of Neurotherapeutics  (2015)

Masitinib for the treatment of mild to moderate Alzheimer’s disease.

Folch, J; Petrov, D; Ettcheto, M; Abat S; Lazarowski A; Marin M.; Olloquequi, J; Auladell, C; Camins, A